The B2 Dog: What Every General Practitioner Should Know About Preclinical Heart Disease With Dr. Visser

A newly ausculted heart murmur is a common encounter in general practice, but navigating what comes next isn’t always straightforward. In this episode of the Partner Podcast, Dr. Lance Visser, board-certified veterinary cardiologist, breaks down the essentials of myxomatous mitral valve disease, including staging and diagnostic criteria, the landmark EPIC trial data, and what the recent approval of VETMEDIN® (pimobendan) by the FDA for the preclinical B2 dogs means for clinical practice.
Sponsored by Boehringer Ingelheim
This podcast is RACE-approved for 1 hour of CE credit through August 5, 2028. Earn your CE credit here (cliniciansbrief.com/continuing-education/sylla…).
Contact us:
• Podcast@instinct.vet
Where to find us:
• Website: CliniciansBrief.com/Podcasts (cliniciansbrief.com/podcasts)
• YouTube: Youtube.com/@clinicians_brief (youtube.com/@clinicians_brief)
• Facebook: Facebook.com/CliniciansBrief (facebook.com/CliniciansBrief)
• LinkedIn: LinkedIn.com/showcase/CliniciansBrief/ (linkedin.com/showcase/CliniciansBrief)
• X: @cliniciansbrief (twitter.com/cliniciansbrief)
• Instagram: @clinicians.brief (instagram.com/clinicians.brief)
The Team:
• Beth Molleson, DVM - Host
• Sarah Pate - Producer & Project Manager, Brief Studio
• Taylor Argo- Podcast Production & Sound Editing